Young H S, Kirby B, Stewart E J
Department of Dermatology, University of Manchester School of Medicine, Hope Hospital, Eccles Old Road, Salford, Manchester M6 8HD, UK.
Clin Exp Dermatol. 2001 Nov;26(8):664-7. doi: 10.1046/j.1365-2230.2001.00913.x.
The association of lower leg ulcer development and hydroxyurea therapy in patients with myeloproliferative disorders has been reported previously. In most of these cases the ulcers healed with cessation of the hydroxyurea together with meticulous attention to wound care. We report a patient who developed painful vasculitic ulcers secondary to hydroxyurea on both lower legs whilst on long-term hydroxyurea therapy for idiopathic thrombocytosis. The ulcers extended relentlessly despite stopping hydroxyurea, maximizing topical therapies and starting intensive systemic treatment. We discuss the association of hydroxyurea therapy with the development of painful ulceration.
先前已有报道骨髓增殖性疾病患者小腿溃疡发展与羟基脲治疗之间的关联。在大多数此类病例中,随着羟基脲停用以及对伤口护理的精心关注,溃疡得以愈合。我们报告了一名患者,该患者在因特发性血小板增多症接受长期羟基脲治疗期间,双侧小腿出现了继发于羟基脲的疼痛性血管炎性溃疡。尽管停用了羟基脲、最大限度地进行了局部治疗并开始了强化全身治疗,但溃疡仍持续蔓延。我们讨论了羟基脲治疗与疼痛性溃疡形成之间的关联。